Hearscape
Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (1 active)
3 results
NS101 by Neuracle Science
Neuracle Science Co., Ltd. · Biologic · Phase 1/2
ActiveTherapeuticStronger sources
Population
Adults · 19–70 years
Steroid-treated persistent unilateral SSNHL
Evidence
trial
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossCochlear Synaptopathy
Details
AM-111 by Auris Medical and Altamira
Altamira Therapeutics · Biologic · Phase 3
DiscontinuedTherapeutic
Population
Adults · ≥18 years
Severe acute unilateral SSNHL
Evidence
company
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing Loss
Details
OTO-413 by Otonomy
Otonomy · Biologic · Phase 2
DiscontinuedTherapeutic
Population
Adults · 21–64 years
Speech-in-noise hearing impairment
Evidence
company
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy
Details

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.

How records are checked